Home Health & Fitness Mosquitoes cannot transmit the coronavirus: Study

Mosquitoes cannot transmit the coronavirus: Study

Home >Science >Health >Mosquitoes cannot transmit the coronavirus: Study

The coronavirus was unable to survive and replicate itself in any of the insects: Study

3 min read

. Updated: 01 Oct 2020, 11:51 AM IST

Nancy Lapid

, Reuters

In laboratory experiments, researchers allowed several species of disease-carrying mosquitoes, plus some other biting insects, to feed on blood spiked with the novel coronavirus

The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.

Mosquitoes cannot transmit COVID-19
A mosquito that bites a person with COVID-19 cannot pass the coronavirus infection to its next victim, according to a study by researchers from U.S. Department of Agriculture and Kansas State University. Mosquitoes are notorious disease carriers, transmitting West Nile virus, Zika, and many other viruses from person to person and among animals. In laboratory experiments, researchers allowed several species of disease-carrying mosquitoes, plus some other biting insects, to feed on blood spiked with the novel coronavirus, SARS-CoV-2. The virus was unable to survive and replicate itself in any of the insects, they reported in a paper posted on Wednesday on bioRxiv ahead of peer review. “Biting insects do not pose a risk for transmission of SARS-CoV-2 to humans or animals,” the researchers said.
Moderna vaccine passes safety test in older patients
Results from an early safety study of Moderna Inc’s coronavirus vaccine candidate in older adults showed that it produced immune responses at levels similar to those seen in younger adults, with side effects roughly on par with high-dose flu shots, researchers reported on Tuesday in The New England Journal of Medicine. The findings are reassuring because immunity tends to weaken with age, coauthor Dr. Evan Anderson of Emory University in Atlanta told Reuters. The trial involved 20 adults aged 56 to 70 and another 20 aged 71 and older. Side effects included headache, fatigue, body aches, chills and injection site pain. In most cases, these were mild to moderate. “This is similar to what a lot of older adults are going to experience with the high dose influenza vaccine,” Anderson said. Moderna is already testing the vaccine in a large Phase III trial, the final stage before seeking emergency authorization or approval.
Hydroxychloroquine fails to prevent COVID-19
A malaria drug taken by U.S. President Donald Trump to prevent COVID-19 did not help prevent coronavirus infections in healthcare workers in a gold-standard randomized controlled trial conducted at the University of Pennsylvania. The new research, published on Wednesday in JAMA Internal Medicine, shows that routine use of the drug, hydroxychloroquine, cannot be recommended to healthcare workers for prevention of COVID-19, researchers said. The study largely confirms results from a similar trial conducted at the University of Minnesota in which hydroxychloroquine failed to prevent infection among people exposed to the new coronavirus.
Immune differences seen in children with inflammatory syndrome after COVID-19
A new study may shed light on why some youngsters develop the rare and dangerous multisystem inflammatory syndrome in children (MIS-C) after recovering from COVID-19 while most do not. The syndrome can cause severe inflammation of blood vessels, the heart, lungs, kidneys, and other organs. The immune system is more highly activated in children with MIS-C than in those with COVID-19, study co-author Dr. John Wherry of University of Pennsylvania Perelman School of Medicine told Reuters. However, in MIS-C patients, the activated immune system quickly settles down, and symptoms improve, often faster than during a bout with COVID-19. Wherry noted a possible connection between a specific type of activated immune cell in children with MIS-C and some of the vascular complications seen in that condition as well as in COVID-19. “The identification of an immune cell type connected to vascular symptoms may identify a new (treatment) target if approaches can be developed to target such cells,” he said. The study was published on Sunday on medRxiv ahead of peer review.
This story has been published from a wire agency feed without modifications to the text. Only the headline has been changed.

Subscribe to Mint Newsletters

* Enter a valid email
* Thank you for subscribing to our newsletter.

Click here to read the Mint ePapermint is now on Telegram. Join mint channel in your Telegram and stay updated



Read More


Please enter your comment!
Please enter your name here

- Advertisment -

Most Popular

How can I tell the difference between the flu and COVID-19?

Last Updated : Oct 01, 2020 01:54 PM IST | Source: AP Body aches, sore throat, fever, cough, shortness of breath, fatigue and headaches are symptoms shared by the two. How can I tell the difference between the flu and COVID-19?It’s impossible to tell without a test. Influenza and COVID-19 have such similar symptoms, you…

Cardiac arrest common in sick Covid-19 patients

Photo for representational purpose only. iStock New York, October 1 Cardiac arrest is common in critically ill patients with Covid-19 and is associated with poor survival, particularly among patients aged 80 or older, say researchers. The findings, published in the journal The BMJ, could help guide end-of-life care discussions with critically ill patients with Covid-19…

Beware: Vitamin D deficiency can make you obese and lead to stunted growth

Vitamin D, or the ‘Sunshine Vitamin as it is also known as, is one of the essential nutrients that makes your bones and teeth stronger, wards off infections and diseases and keeps you cheerful. This fat-soluble vitamin can also bring down your risk of cancer, autoimmune diseases, heart disease and diabetes. But unfortunately, as many…

COVID-19 cases decline, deaths increase in Chandigarh as September ends

Naina MishraTribune News ServiceChandigarh, October 1 As September comes to an end, the Union Territory has started to witness a decline in the number of positive COVID-19 cases, and daily tests.  However, COVID deaths have increased with every passing week.  September has recorded 100 COVID-19 deaths whereas August reported only 39 deaths.  At least three…

Recent Comments